Ai Healthcare openbaar
[search 0]
Meer
Download the App!
show episodes
 
Artwork
 
AI and Healthcare—with Mika Newton and Dr. Sanjay Juneja is an engaging interview series featuring world-renowned leaders shaping the intersection of artificial intelligence and medicine. Discover how AI is transforming healthcare today, addressing real-world challenges and improving patient outcomes. This series caters to anyone’s listening style with bite-sized, commute-friendly insights and full-length interviews. Join co-hosts Mika Newton, CEO of xCures, and Dr. Sanjay Juneja, a globally ...
  continue reading
 
Bringing doctors and developers together to unlock the potential of AI in healthcare. Together, we can build models that matter. 🤖👨🏻‍⚕️ Hello! We are Dev & Doc, Zeljko and Josh :) Josh is a Neurologist, AI Researcher and Clinical AI Lead. Zeljko is an AI engineer, CTO and associate professor (UCL) ------------- Substack- https://aiforhealthcare.substack.com/ YT - https://youtube.com/@DevAndDoc
  continue reading
 
Artwork

1
AI-ready Healthcare

Anirban Mukhopadhyay, Henry Krumb

icon
Unsubscribe
icon
Unsubscribe
Maandelijks
 
Deep meaningful discussions for Knowledge dissemination and constructive arguments, with a shared mission about making Healthcare AI-ready. I invite stakeholders such as clinicians, AI experts, industry personnel and regulatory personnel to talk about the translational aspects of AI research into patient care. Often we converse with my co-host Henry Krumb.
  continue reading
 
New podcast weblog“AI Revolution in Healthcare: A Regulatory Perspective with Dr. Nirdosh Jagota” is your gateway to understanding the intersection of artificial intelligence and healthcare regulation. Hosted by Dr. Nirdosh Jagota—a seasoned expert with over 30 years in the biotech and pharmaceutical sectors—this podcast explores how AI is reshaping every aspect of healthcare, from drug discovery to patient care, and the regulatory frameworks that support this transformation. In each episode ...
  continue reading
 
Loading …
show series
 
body{font-family:sans-serif;color:#fff;background:#121212;margin:0;padding:10px}p{margin:8px 0}h1{font-size:18px;margin:10px 0}.note{background:#535353;padding:10px;border-radius:4px;margin:10px 0}.timestamps span{color:#1DB954;font-weight:bold}a{color:#1DB954;text-decoration:none} Can Claude perform a range of complex clinical tasks? Dev and Doc a…
  continue reading
 
This podcast episode explores the intersection of AI and healthcare, focusing on drug development, repurposing, and access to medical treatments. Mika Newton speaks with Bob Battista about the challenges of sharing pharmaceutical data, regulatory barriers, and how AI could enhance clinical decision-making. They discuss real-world data, patient know…
  continue reading
 
In the season finale of AI Revolution in Healthcare: A Regulatory Perspective, Dr. Nirdosh Jagota reflects on the future of AI in healthcare, looking ahead to 2030 and beyond. This episode brings together key themes from the series to explore how healthcare innovation, regulatory frameworks, and patient safety will evolve in the years to come. Dr. …
  continue reading
 
In this thought-provoking episode of AI Revolution in Healthcare: A Regulatory Perspective, Dr. Nirdosh Jagota explores the vital topics of ethics and patient privacy in AI-powered healthcare systems. As AI becomes increasingly involved in medical decision-making, issues such as accountability, transparency, and fairness take center stage. Dr. Jago…
  continue reading
 
In this episode of AI Revolution in Healthcare: A Regulatory Perspective, Dr. Nirdosh Jagota examines the global regulatory landscape for AI in healthcare. As AI technologies transcend borders, understanding the similarities and differences between regulatory frameworks is critical for innovators seeking worldwide implementation. Dr. Jagota explore…
  continue reading
 
In this episode of AI Revolution in Healthcare: A Regulatory Perspective, Dr. Nirdosh Jagota explores the vital process of validation and verification for AI systems in healthcare, emphasizing their role in ensuring safety and effectiveness for patient care. Dr. Jagota breaks down the unique challenges AI systems present compared to traditional med…
  continue reading
 
In this episode of AI Revolution in Healthcare: A Regulatory Perspective, Dr. Nirdosh Jagota dives into the transformative role of artificial intelligence in drug safety and pharmacovigilance. With the ability to process thousands of adverse event reports daily, AI is reshaping how pharmaceutical companies identify and respond to safety signals, en…
  continue reading
 
Is it still worth doing a PhD in 2025? Is the academic system broken in this publish-or-perish landscape? When is a PhD not worth pursuing? About this Episode In this Dev and Doc episode, Zeljko (now associate professor!) and Josh (doctor, PhD drop out) talk about the good and the bad of PhD life. They provide insight into the academic world with a…
  continue reading
 
Mika Newton and Bob Battista explore how AI could reshape healthcare by giving patients greater control over their medical decisions. They discuss the potential for AI to process vast amounts of clinical data, improve access to relevant treatments, and bridge gaps in health literacy. The conversation also raises important questions about data shari…
  continue reading
 
Mika Newton and Bob Battista discuss how AI is shaping healthcare decision-making. They explore its role in analyzing clinical evidence, updating guidelines dynamically, and personalizing treatment recommendations. The conversation also highlights challenges like regulatory restrictions and data silos that limit AI’s full potential in the industry.…
  continue reading
 
Drug repurposing offers a way to find new treatments using existing medications, but regulatory hurdles and financial disincentives often prevent progress. Mika Newton and Bob Battista examine the challenges of data sharing in the pharmaceutical industry, the high costs of clinical trials, and why companies hesitate to pursue niche indications. The…
  continue reading
 
Dev and Doc put Deepseek R1 to the test in a technical and clinical deep dive. 👋 Hey! If you are enjoying our conversations, reach out, share your thoughts and journey with us. Don't forget to subscribe whilst you're here :) 👨🏻‍⚕️Doc - Dr. Joshua Au Yeung - https://www.linkedin.com/in/dr-joshua-au-yeung/ 🤖Dev - Zeljko Kraljevic https://twitter.com/…
  continue reading
 
Mika Newton and Tom Neyarapally discuss how AI is changing the landscape of drug discovery. They examine the role of machine learning, patient data, and computational tools in accelerating the process, reducing costs, and improving the chances of developing effective treatments. The conversation covers how AI-driven screening, drug repurposing, and…
  continue reading
 
Mika Newton and Tom Neyarapally explore how advancements in AI are accelerating the development of new algorithms, improving target discovery, and enhancing high-throughput screening. The conversation highlights the challenges and opportunities in aggregating innovative technologies, the convergence of AI tools in healthcare, and the potential for …
  continue reading
 
Explore how AI is transforming drug discovery by enabling the rapid screening of billions of molecules and identifying new uses for existing drugs. This approach integrates patient data with advanced tools to predict effective treatments for diseases with unmet medical needs, significantly reducing the time and cost of development.…
  continue reading
 
In this episode, Dr. Sanjay Janeja and Dr. Debra Patt discuss AI in healthcare. They cover its applications in cancer care, from improving diagnostics and treatment decisions to enhancing patient education and real-time symptom management. The conversation also highlights AI's potential in drug discovery, reducing healthcare costs, optimizing admin…
  continue reading
 
Mika Newton and Tom Neyarapally discuss how advancements in data, AI tools, and computing power are transforming drug discovery, particularly in oncology. They explore patient-centric approaches, in silico screening, and strategies to reduce the time and cost of bringing new treatments to market.Door xCures
  continue reading
 
An overview of ASCO's approach to artificial intelligence in cancer care, focusing on responsible use, transparency, and the importance of keeping physicians at the center of decision-making. The clip discusses guidelines, challenges like biases and model limitations, and how AI can complement personalized care.…
  continue reading
 
Dev and Doc - Latest News Dev and Doc - Latest News It's 2025, Dev and Doc cover the latest news including Google's deep research and notebook LM, DeepMind's Promptbreeder, and Anthropic's new RAG approach. We also go through what retrieval augmented generation (RAG) is, and how this technique is advancing LLM performance. 👋 Hey! If you are enjoyin…
  continue reading
 
Dr. Debra Patt and Dr. Sanjay Juneja explore how AI is reshaping healthcare, focusing on its impact on physicians and patient care. Discover how AI tools are seamlessly integrated into care delivery, from enhancing cancer diagnostics and automating clinical documentation to improving administrative efficiency. Learn about AI-powered scribe services…
  continue reading
 
Dr. Juneja and Dr. Patt discuss the financial implications of AI adoption, how tools like ambient listening and real-time monitoring can enhance patient care, and the role of AI in educating patients to manage treatment toxicities. Plus, they dive into the advancements in drug discovery and clinical trials, where AI is paving the way for more effic…
  continue reading
 
Drew Williamson is a board certified pathologist who is focusing on pathology AI. Drew is part of the Emory Empathetic AI for Health Institute and the AI.Humanity initiative at Emory University, Atlanta, USA. We will hear all about his exciting research on clinical translation of Pathology AI. A multimodal generative AI copilot for human pathology…
  continue reading
 
Welcome to Healthcare: AI In Review! Our guest: Nicole Bell, Chief Commercial Officer at Curai Health Moderated By Missy Krasner, Gen AI Investor/Board Advisor In this episode, we discussed: Nicole Bell shares her career journey and her work at Curai Health. Curai Health’s AI-driven care model supports longitudinal primary care. Transitioning from …
  continue reading
 
Welcome to Healthcare: AI In Review! Our guest: Bevey Miner, EVP Healthcare Strategy & Policy at Consensus Cloud Solutions Moderated By Missy Krasner, Gen AI Investor/Board Advisor In this episode, we discussed: Bevey Miner's Expertise: EVP Healthcare Strategy & Policy at Consensus Cloud Solutions, discussing the transformative impact of AI on unst…
  continue reading
 
Welcome to Healthcare: AI In Review! Our guest: Patrick Hawthorne, SVP Pharmacy Network Partners at MedAdvisor Solutions US Moderated By Missy Krasner, Gen AI Investor/Board Advisor In this episode, we discussed: MedAdvisor's Role in Medication Adherence: Patrick Hawthorne explains MedAdvisor's omnichannel tactics for improving patient adherence. A…
  continue reading
 
Welcome to Healthcare: AI In Review! Our guest: Fawad Butt, Founder & CEO at Penquin Ai Moderated By Missy Krasner, Gen AI Investor/Board Advisor In this episode, we discussed: Fawad Butt's Background: Former Chief Data Officer at Optum and UnitedHealthcare, now leading Penguin AI. Penguin AI Launch: Emerging from stealth mode to tackle administrat…
  continue reading
 
In this episode, Dr. Sanjay Juneja is joined by Mika Newton, CEO of xCures, to explore how AI is transforming the future of medicine. Together, they discuss tackling critical challenges like resource shortages, improving patient triaging, and leveraging data for smarter, faster decision-making. Mika shares his unique insights on how technology is r…
  continue reading
 
Professor Randy Ellis is a legendary figure within the computer-assisted orthopedic surgery community. His primary appointment is in the School of Computing with additional appointments at the Mechanical and Materials Engineering, Surgery, and Biomedical and Molecular Sciences at the Queen's University, Canada. He has been a Fellow of several organ…
  continue reading
 
Uta Schmidt-Strassburer is the scientific director of the Advanced Oncology study program at the Ulm university Germany. She is also a fellow podcaster, running the bilingual "caring and sharing" podcast on advanced oncology. Over the years, Uta has developed a critical appreciation towards oncology AI.…
  continue reading
 
In this episode of AI Revolution in Healthcare: A Regulatory Perspective, Dr. Nirdosh Jagota explores the innovative concept of Predetermined Change Control Plans (PCCPs) for AI and machine learning-enabled medical devices. PCCPs offer a regulatory solution to the challenge of managing evolving AI systems that learn and adapt over time. Dr. Jagota …
  continue reading
 
In this episode of AI Revolution in Healthcare: A Regulatory Perspective, Dr. Nirdosh Jagota explores how artificial intelligence is transforming pharmaceutical manufacturing, particularly in quality control. Titled "Quality Control and AI: Ensuring Safety in Drug Manufacturing," this episode delves into the intersection of AI and regulatory compli…
  continue reading
 
In this episode of AI Revolution in Healthcare: A Regulatory Perspective, Dr. Nirdosh Jagota explores the transformative role of machine learning in medical imaging and its regulatory journey. He highlights a Swedish study where AI-assisted breast cancer screening improved detection rates by 4% compared to traditional methods. Dr. Jagota examines t…
  continue reading
 
In this episode of AI Revolution in Healthcare: A Regulatory Perspective, Dr. Nirdosh Jagota dives into the transformative role of artificial intelligence in clinical trials and drug development. Titled "Artificial Intelligence in Clinical Trials: Transforming Drug Development," Dr. Jagota discusses how AI is addressing critical challenges in clini…
  continue reading
 
Join Dr. Sanjay Juneja, known as the OncDoc, as he discusses the complex intersection of endocrinology and oncology with Dr. Afreen Shariff, an expert endo-oncologist from Duke University. This episode explores the often-overlooked endocrine side effects of cancer treatments, such as steroids and immune therapies, and how they impact patient qualit…
  continue reading
 
In the very first episode of "AI Revolution in Healthcare: A Regulatory Perspective," Dr. Nirdosh Jagota takes listeners on a journey to explore how artificial intelligence is transforming healthcare and what it means for regulatory processes. In this episode, titled "The Dawn of AI in Healthcare: Understanding the Regulatory Landscape," Dr. Jagota…
  continue reading
 
Michael Levin is a Distinguished Professor in the Biology at Tufts. Mike also serves as the director of the Allen Discovery Center at Tufts and the Tufts Center for Regenerative and Developmental Biology. He is a computer scientist by training, looking at some of the most fundamental questions of biology such as pattern formation, embryogenesis and…
  continue reading
 
In this episode of the Target Cancer Podcast, Dr. Sanjay Juneja sits down with Dr. Tim Showalter, Chief Medical Officer at Artera, to explore the transformative role of AI in personalizing cancer treatment. Dr. Showalter shares insights on how advanced AI tools are helping clinicians make more precise decisions, reducing overtreatment, and improvin…
  continue reading
 
Welcome to Healthcare: AI In Review! Our guests: Brian Anderson, President & CEO at Coalition for Health AI Randi E Seigel, Helathcare Regulatory Lawyer at Manatt Phelps & Phillips Moderated By Missy Krasner, Gen AI Investor/Board Advisor In this episode, we discussed: Coalition for Health AI's Mission: Brian Anderson shares the Coalition’s goals t…
  continue reading
 
In this engaging episode of the 'Target: Cancer Podcast,' Dr. Sanjay Juneja discusses the future of healthcare data with Therasa Bell, President, CTO, and co-founder of Kno2. Covering themes of healthcare inefficiencies, the importance of data sharing, and the critical need for innovation, this conversation dives deep into ways to tackle pressing c…
  continue reading
 
First Thoughts and Preliminary Insights into OpenAI's GPT o1 Strawberry in the Medical Domain With some expected and unexpected findings, we have a "bake off" between o1 and Doc to demonstrate how o1 fares with tricky medical scenarios. Disclaimer Obviously, don't use AI to diagnose or treat your medical problems. If you are unwell, please seek a m…
  continue reading
 
In this eye-opening episode, Dr. Sanjay Juneja teams up with leading experts Dr. Jason Fung and Dr. Thomas Seyfried to reveal the shocking truth about what really drives cancer growth. Forget everything you thought you knew—this isn’t just about genetics! They dive into the powerful connection between diet, insulin, and metabolism, and how controll…
  continue reading
 
Dr. Lim takes us through the evolution of personalized cancer therapy, starting from animal trials and advancing to human treatments. He explains how artificial intelligence is playing a critical role in creating precise and effective treatment plans in oncology. Explore the impact of AI in transforming cancer care by offering more personalized the…
  continue reading
 
Maciej Mazurowski is an Associate Professor of Radiology, Electrical and Computer Engineering, Biostatistics and Bioinformatics, and Computer Science at Duke University. He is also the Scientific Director of the Duke Center for Artificial Intelligence in Radiology and the Director of Radiology Imaging at Duke AI Health. His interest includes domain…
  continue reading
 
Dev and Doc is joined by guest Annabelle Painter, doctor, CMO, and podcaster for the Royal Society of Medicine Digital Health Podcast. We deep dive into explainability and interpretability with concrete healthcare examples. Check out Dr. Painter's Podcast here, she has some amazing guests and great insights into AI in healthcare! - https://spotify.…
  continue reading
 
Loading …

Korte handleiding

Luister naar deze show terwijl je op verkenning gaat
Spelen